Solvias, a leading provider of laboratory testing services, has announced plans to expand its global network with a new biotech site in Research Triangle Park, N.C. The 50,000-square-foot facility is expected to be completed in 2025 and will bring over
Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, announced on January 23, 2024, that it will perform analytical release testing services on the world’s first CRISPR/Cas9 genome-edited cell therapy. The announcement was made from the company’s headquarters in
Solvias is a Contract Research Organisation (CRO) company operating in the pharmaceutical industry. Solvias is a world leader in contract research, development and manufacturing. The industries we serve include pharmaceuticals, biotech, medical devices and cosmetics. Solvias is headquartered near Basel,
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
